polyethylene glycol 3350 GoLYTELY
Selected indexed studies
- Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. (JAMA Intern Med, 2014) [PMID:25243839]
- Measurement of Polyethylene Glycol 3350 With Standard Household Measuring Devices. (J Pediatr Pharmacol Ther, 2024) [PMID:38863850]
- Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints. (Can J Gastroenterol Hepatol, 2022) [PMID:36120087]
_Worker-drafted node — pending editorial review._
Connections
polyethylene glycol 3350 GoLYTELY is a side effect of
Sources
- Polyethylene glycol 3350 without electrolytes for treatment of childhood constipation. (2009) pubmed
- OTC polyethylene glycol 3350 and pharmacists' role in managing constipation. (2012) pubmed
- Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. (2014) pubmed
- Measurement of Polyethylene Glycol 3350 With Standard Household Measuring Devices. (2024) pubmed
- Over-the-counter laxative polyethylene glycol 3350: an evidence-based appraisal. (2011) pubmed
- Polyethylene Glycol 3350 Crystal Nephropathy in Association With Glomerular Mesangial Immunoglobin A Deposition. (2022) pubmed
- Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints. (2022) pubmed
- Polyethylene glycol 3350 plus electrolytes for pediatric chronic constipation: An open-label clinical study in Japan. (2020) pubmed
- Comparison of Polyethylene Glycol 3350+Electrolytes vs. Polyethylene Glycol 4000 for Fecal Disimpaction in Pediatric Functional Constipation: A Double-Blind Randomized Controlled Trial. (2025) pubmed
- Polyethylene Glycol 3350 (PEG 3350) as a Practical Vehicle for Rapid Reconstitution of PARPi-FL Formulations for Clinical Use. (2023) pubmed